Growth Stage

Breakthrough Technology For The Nervous System

Breakthrough Technology For The Nervous System


Raised this Round: Raised: $6,200,610

Total Commitments ($USD)


Dealmaker Securities

Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common



SEC Filing Type

RegA+    Open SEC Filing

Price Per Share


Pre-Money Valuation


Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



The Woodlands, Texas

Business Type


Autonomix, with a valuation of $70 million, is raising funds independently through Reg A+ crowdfunding. The company is developing a two-fold technology to detect malfunctioning neural signals and ablate nerves. Autonomix is opening up a world of possibilities in electrophysiology and working towards creating a simple procedure for pain management. The company is currently targeting pancreatic cancer pain and aims to target chronic pain, cardiovascular pain, and pulmonary diseases in the future. Dr. Robert Schwartz, Landy Roth, David Robins, and Dr. Robert Van Tassel founded Autonomix in 2014. The current crowdfunding campaign has a maximum target of $21.2 million. The campaign proceeds will be used for marketing, publishing, underwriting expenses, legal & accounting fees, and transfer agent.

Balance Sheet

Cash and Cash Equivalents


Investment Securities


Accounts and Notes Receivable


Property, Plant and Equipment (PP&E)


Property and Equipment


Total Assets


Accounts Payable & Accrued Liabilities


Long Term Debt


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Total Revenues


Costs & Expenses Applicable to Rev


Depreciation and Amortization


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Auditor: FORVIS, LLP
Financials as of: 10/18/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Autonomix on Self Managed 2023
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $70,000,000
Price per Share: $5.00

Follow company

Follow Autonomix on Self Managed 2023

Buy Autonomix's Deal Report

Warning: according to the close date for this deal, Autonomix may no longer be accepting investments.

Autonomix Deal Report

Get KingsCrowd’s comprehensive report on Autonomix including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Autonomix is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Autonomix deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge